CP690550 also significantly inhibited IL-6-mediated gene expression to ameliorate IDD by pharmacological inhibition of JAK3 activity (Ohtori et al., 2012; Suzuki et al., 2017). The gene discussed is IL6; the disease is intervertebral disk degenerative disorder.